Pelvic radiotherapy with concurrent 5-fluorouracil modulated by leucovorin for rectal cancer: a phase II study (Q72871387)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Pelvic radiotherapy with concurrent 5-fluorouracil modulated by leucovorin for rectal cancer: a phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

S G Cooper

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

A Bonaventura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

S P Ackland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

D J Joseph

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

J F Stewart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

C S Hamilton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

J W Denham

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

169-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Survival following moderate-dose preoperative radiation therapy for carcinoma of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Preoperative radiation therapy for rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Postoperative adjuvant radiotherapy for adenocarcinoma of the rectum and rectosigmoid

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Postoperative radiation therapy of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma. Trial of the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research on Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Survival after postoperative combination treatment of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Prolongation of the disease-free interval in surgically treated rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980319-X

7 January 2021

10.1016/S0936-6555(05)80319-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347540%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference